Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

Biological E will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.

The implementation of these three key pillars — vaccination, screening, and treatment — are critical in eliminating cervical ...

Low screening coverage, late diagnoses, high HIV prevalence, and limited access to treatment and vaccines are driving cervical cancer cases and deaths in South Africa. The country has a cervical ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...

The US Secretary of Health and Human Services insists he will soon announce the "cause" of autism, but setting a fixed ...

A woman who survived cervical cancer says she is concerned about changes to cervical screening that come into effect today.

ROCK star David Roach has been diagnosed with a “very aggressive” form of cancer after symptoms of a “fever and a cough”. The ...

HYDERABAD: Jiangsu Recbio Technology Co. Ltd, a leading Chinese biopharmaceutical firm, has entered into a licensing and ...

Jiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to ...

Head and neck cancer is a term that covers a range of cancers that can have a big impact on everyday life.Here are 6 ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...